Annual EPS
-$49.80
-$52.80-1760.00%
31 December 2023
Summary:
Cartesian Therapeutics annual earnings per share is currently -$49.80, with the most recent change of -$52.80 (-1760.00%) on 31 December 2023. During the last 3 years, it has fallen by -$29.40 (-144.12%). RNAC annual EPS is now -1760.00% below its all-time high of $3.00, reached on 31 December 2022.RNAC EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$3.39
-$3.93-727.78%
01 September 2024
Summary:
Cartesian Therapeutics quarterly earnings per share is currently -$3.39, with the most recent change of -$3.93 (-727.78%) on 01 September 2024. Over the past year, it has dropped by -$1.65 (-94.83%). RNAC quarterly EPS is now -241.25% below its all-time high of $2.40, reached on 01 March 2022.RNAC Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$54.95
-$1.65-3.10%
01 September 2024
Summary:
Cartesian Therapeutics TTM earnings per share is currently -$54.95, with the most recent change of -$1.65 (-3.10%) on 01 September 2024. Over the past year, it has dropped by -$45.24 (-465.91%). RNAC TTM EPS is now -1626.39% below its all-time high of $3.60, reached on 01 September 2022.RNAC TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1760.0% | -94.8% | -465.9% |
| 3 y3 years | -144.1% | +29.4% | -250.8% |
| 5 y5 years | +43.1% | +56.5% | -15.2% |
RNAC EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1760.0% | at low | -241.3% | +91.8% | -1626.4% | +2.0% |
| 5 y | 5 years | -1760.0% | +43.1% | -241.3% | +91.8% | -1626.4% | +2.0% |
| alltime | all time | -1760.0% | +57.3% | -241.3% | +95.9% | -1626.4% | +61.6% |
Cartesian Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.39(-727.8%) | -$54.95(+3.1%) |
| June 2024 | - | $0.54(-105.1%) | -$53.30(-4.9%) |
| Mar 2024 | - | -$10.50(-74.8%) | -$56.07(+12.6%) |
| Dec 2023 | -$49.80(-1760.0%) | -$41.60(+2290.8%) | -$49.81(+413.0%) |
| Sept 2023 | - | -$1.74(-22.0%) | -$9.71(+2.5%) |
| June 2023 | - | -$2.23(-47.4%) | -$9.47(+74.1%) |
| Mar 2023 | - | -$4.24(+182.7%) | -$5.44(-553.3%) |
| Dec 2022 | $3.00(-145.5%) | - | - |
| Dec 2022 | - | -$1.50(0.0%) | $1.20(-66.7%) |
| Sept 2022 | - | -$1.50(-183.3%) | $3.60(+1100.0%) |
| June 2022 | - | $1.80(-25.0%) | $0.30(-119.2%) |
| Mar 2022 | - | $2.40(+166.7%) | -$1.56(-85.2%) |
| Dec 2021 | -$6.60(-67.6%) | $0.90(-118.8%) | -$10.56(-32.6%) |
| Sept 2021 | - | -$4.80(+7507.0%) | -$15.66(+15.5%) |
| June 2021 | - | -$0.06(-99.0%) | -$13.56(-35.4%) |
| Mar 2021 | - | -$6.60(+57.1%) | -$21.00(+1.4%) |
| Dec 2020 | -$20.40(-44.3%) | -$4.20(+55.6%) | -$20.70(-16.9%) |
| Sept 2020 | - | -$2.70(-64.0%) | -$24.90(-17.0%) |
| June 2020 | - | -$7.50(+19.0%) | -$30.00(-10.7%) |
| Mar 2020 | - | -$6.30(-25.0%) | -$33.60(-8.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$36.60(-58.2%) | -$8.40(+7.7%) | -$36.60(-23.3%) |
| Sept 2019 | - | -$7.80(-29.7%) | -$47.70(-22.1%) |
| June 2019 | - | -$11.10(+19.4%) | -$61.20(-18.7%) |
| Mar 2019 | - | -$9.30(-52.3%) | -$75.30(-13.7%) |
| Dec 2018 | -$87.60(-8.8%) | -$19.50(-8.5%) | -$87.30(-7.3%) |
| Sept 2018 | - | -$21.30(-15.5%) | -$94.20(+1.6%) |
| June 2018 | - | -$25.20(+18.3%) | -$92.70(-0.3%) |
| Mar 2018 | - | -$21.30(-19.3%) | -$93.00(-3.4%) |
| Dec 2017 | -$96.00(-17.7%) | -$26.40(+33.3%) | -$96.30(+3.5%) |
| Sept 2017 | - | -$19.80(-22.4%) | -$93.00(+8.0%) |
| June 2017 | - | -$25.50(+3.7%) | -$86.10(-39.8%) |
| Mar 2017 | - | -$24.60(+6.5%) | -$143.10(+5.3%) |
| Dec 2016 | -$116.70(+54.0%) | -$23.10(+79.1%) | -$135.94(+1.2%) |
| Sept 2016 | - | -$12.90(-84.4%) | -$134.34(-3.4%) |
| June 2016 | - | -$82.50(+373.1%) | -$139.07(+82.5%) |
| Mar 2016 | - | -$17.44(-18.9%) | -$76.22(+0.6%) |
| Dec 2015 | -$75.79(+98.6%) | -$21.51(+22.0%) | -$75.79(+39.6%) |
| Sept 2015 | - | -$17.63(-10.3%) | -$54.28(+48.1%) |
| June 2015 | - | -$19.65(+15.6%) | -$36.65(+115.6%) |
| Mar 2015 | - | -$17.00 | -$17.00 |
| Dec 2014 | -$38.17 | - | - |
FAQ
- What is Cartesian Therapeutics annual earnings per share?
- What is the all time high annual EPS for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual EPS year-on-year change?
- What is Cartesian Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly EPS year-on-year change?
- What is Cartesian Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Cartesian Therapeutics?
- What is Cartesian Therapeutics TTM EPS year-on-year change?
What is Cartesian Therapeutics annual earnings per share?
The current annual EPS of RNAC is -$49.80
What is the all time high annual EPS for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual earnings per share is $3.00
What is Cartesian Therapeutics annual EPS year-on-year change?
Over the past year, RNAC annual earnings per share has changed by -$52.80 (-1760.00%)
What is Cartesian Therapeutics quarterly earnings per share?
The current quarterly EPS of RNAC is -$3.39
What is the all time high quarterly EPS for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly earnings per share is $2.40
What is Cartesian Therapeutics quarterly EPS year-on-year change?
Over the past year, RNAC quarterly earnings per share has changed by -$1.65 (-94.83%)
What is Cartesian Therapeutics TTM earnings per share?
The current TTM EPS of RNAC is -$54.95
What is the all time high TTM EPS for Cartesian Therapeutics?
Cartesian Therapeutics all-time high TTM earnings per share is $3.60
What is Cartesian Therapeutics TTM EPS year-on-year change?
Over the past year, RNAC TTM earnings per share has changed by -$45.24 (-465.91%)